Topological Mechanisms of DNA Break Repair in Lymphocytes

淋巴细胞DNA断裂修复的拓扑机制

基本信息

  • 批准号:
    9899620
  • 负责人:
  • 金额:
    $ 39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2021-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Our genomes are subject to a constant barrage of damage from reactive metabolites, environmental agents, or physiologic processes. A major form of physiologic damage is DNA double-strand breaks (DSBs) arising from transcription and replication. Developing lymphocytes also target DSBs to antigen receptor (AgR) loci as part of their assembly by V(D)J recombination. To maintain genomic stability, DSBs must be repaired with high fidelity, minimizing oncogenic alterations such as chromosomal deletions and translocations. The DSB response leads to extensive revision of flanking chromatin, including phosphorylation of the histone variant H2AX by the damage-sensing kinase ATM. Phosphorylated H2AX (-H2AX) spreads for 100s of kb from a DSB. In non-cycling cells, the -H2AX domain serves as a chromatin-based platform to facilitate repair by the non-homologous end joining (NHEJ) machinery and, perhaps, as an adherent surface to hold broken chromosome ends together. Indeed, broken chromosomes are destabilized in cells deficient for ATM or H2AX, which have elevated levels of translocations. Thus, a deeper understanding of mechanisms that coordinate DSB repair and sequester lesions from other parts of the genome remains an important goal in cancer biology. In this regard, mechanistic links between DNA repair, transcription, and epigenetic landscapes around DSBs are beginning to emerge. A feature that may bridge these processes is the 3D conformation of chromatin flanking a DSB. However, the impact of DSBs on genome conformation and, conversely, the role of its reconfiguration in stabilizing DNA ends for repair, remain unexplored. Conformational mechanisms are likely important to generate compact platforms for repair complexes and to spatially restrict DSBs from other regions of the genome. A breakdown in these processes may destabilize unrepaired chromosome ends, allowing them to drift apart or to participate in translocations. The applicant has discovered that DSBs in precursor lymphocytes induce compaction of chromatin over 100s of kb flanking DSB sites in AgR loci, paralleling the spread of -H2AX. Borders of compacted -H2AX domains correspond with those of topologically associated domains (TADs), the architectural building blocks of chromosome structure. Launching from these discoveries, the overarching hypothesis of the project is that -H2AX domains are limited by inherent topological features around the DSB site, forming a spatially compact platform to stabilize association of chromosome ends and focus repair. Three aspects of the hypothesis will be studied: (i) how DSB location within a TAD affects the intensity and breadth of -H2AX domains, linking these features to translocation potential, (ii) how damage response factors mediate DSB-induced conformational changes and end stabilization, and (iii) how DSBs impact structural and regulatory loops that drive gene expression. Findings from this project will advance the field, providing new insights into how DSB responses integrate spatial, transcriptional, and chromatin-based mechanisms to sequester chromosome ends for efficient repair, minimizing their oncogenic potential.
 描述(由申请人提供):我们的基因组不断受到反应性代谢物、环境因素或生理过程的破坏。生理损伤的一种主要形式是由转录和复制引起的DNA双链断裂。发育中的淋巴细胞也通过V(D)J重组将DSB靶向抗原受体(AGR)基因座作为其组装的一部分。为了保持基因组的稳定性,必须高保真地修复DSB,将染色体缺失和易位等致癌改变降至最低。DSB反应导致侧翼染色质的广泛修改,包括组蛋白变异体H2AX被损伤敏感激酶ATM磷酸化。磷酸化的H_2AX(-H_2AX)从DSB扩散到100s kb。在非周期细胞中,-H2AX结构域作为一个以染色质为基础的平台,促进非同源末端连接(NHEJ)机制的修复,也可能作为一个黏附表面将断裂的染色体末端结合在一起。事实上,在缺乏ATM或H2AX的细胞中,断裂的染色体会变得不稳定,因为这些细胞的易位水平较高。因此,更深入地了解协调DSB修复和隔离基因组其他部分损伤的机制仍然是癌症生物学的一个重要目标。在这方面,DNA修复、转录和DSB周围的表观遗传景观之间的机械联系开始出现。一个可能连接这些过程的特征是染色质在DSB两侧的3D构象。然而,DSB对基因组构象的影响,以及相反,其重组在稳定DNA末端以供修复方面的作用仍未被探索。构象机制对于生成修复复合体的紧凑平台和在空间上限制来自基因组其他区域的DSB可能是重要的。这些过程的中断可能会破坏未修复的染色体末端的稳定性,使它们漂移或参与易位。申请人已经发现,前体淋巴细胞中的DSB导致AGR基因座DSB位点两侧超过100kb的染色质紧凑,与-H_2AX的扩散平行。致密的-H2AX结构域的边界与拓扑相关结构域(TADS)的边界相对应,拓扑相关结构域是染色体结构的构建块。从这些发现出发,该项目的总体假设是,-H2 AX结构域受到DSB位点周围固有拓扑特征的限制,形成了一个空间紧凑的平台,以稳定染色体末端的关联和焦点修复。该假说的三个方面将被研究:(I)双链断裂在TAD内的位置如何影响-H_2AX结构域的强度和宽度,将这些特征与易位潜能联系起来;(Ii)损伤反应因子如何介导双链断裂诱导的构象变化和末端稳定;以及(Iii)双链断裂如何影响驱动基因表达的结构和调控环。该项目的发现将推动该领域的发展,为DSB反应如何整合空间、转录和染色质机制以隔离染色体末端以实现有效修复提供新的见解,从而将其致癌潜力降至最低。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eugene M Oltz其他文献

Increased COVID-19 Mortality and Deficient SARS-CoV-2 Immune Response Are Not Associated with Higher Levels of Endemic Coronavirus Antibodies
COVID-19 死亡率增加和明确的 SARS-CoV-2 免疫反应与地方性冠状病毒抗体水平升高无关
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bindu Adhikari;Eugene M Oltz;J. Bednash;J. C. Horowitz;J. Amimo;Sergei A. Raev;Soledad Fernández;M. Anghelina;Shan;Mark P. Rubinstein;Daniel M. Jones;Linda J. Saif;A. Vlasova
  • 通讯作者:
    A. Vlasova
Essential function for SWI-SNF chromatin-remodeling complexes in the promoter-directed assembly of Tcrb genes
SWI-SNF 染色质重塑复合物在 Tcrb 基因启动子指导组装中的基本功能
  • DOI:
    10.1038/ni1481
  • 发表时间:
    2007-06-24
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Oleg Osipovich;Robin Milley Cobb;Kenneth J Oestreich;Steven Pierce;Pierre Ferrier;Eugene M Oltz
  • 通讯作者:
    Eugene M Oltz

Eugene M Oltz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eugene M Oltz', 18)}}的其他基金

Project 1: COVID-19 prevalence, transmission, and protection in extended first responder cohorts
项目 1:扩大急救人员群体中的 COVID-19 流行率、传播和保护
  • 批准号:
    10688392
  • 财政年份:
    2020
  • 资助金额:
    $ 39万
  • 项目类别:
Core B: Testing and Biorepository
核心 B:测试和生物样本库
  • 批准号:
    10688388
  • 财政年份:
    2020
  • 资助金额:
    $ 39万
  • 项目类别:
Core B: Testing and Biorepository
核心 B:测试和生物样本库
  • 批准号:
    10222408
  • 财政年份:
    2020
  • 资助金额:
    $ 39万
  • 项目类别:
Project 1: COVID-19 prevalence, transmission, and protection in extended first responder cohorts
项目 1:扩大急救人员群体中的 COVID-19 流行率、传播和保护
  • 批准号:
    10222410
  • 财政年份:
    2020
  • 资助金额:
    $ 39万
  • 项目类别:
SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA
序列特异性染色质修饰剂;
  • 批准号:
    8885259
  • 财政年份:
    2015
  • 资助金额:
    $ 39万
  • 项目类别:
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES
淋巴细胞 DNA 断裂修复的拓扑机制
  • 批准号:
    10663321
  • 财政年份:
    2015
  • 资助金额:
    $ 39万
  • 项目类别:
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES
淋巴细胞 DNA 断裂修复的拓扑机制
  • 批准号:
    10415222
  • 财政年份:
    2015
  • 资助金额:
    $ 39万
  • 项目类别:
TOPOLOGICAL MECHANISMS OF DNA BREAK REPAIR IN LYMPHOCYTES
淋巴细胞 DNA 断裂修复的拓扑机制
  • 批准号:
    10305139
  • 财政年份:
    2015
  • 资助金额:
    $ 39万
  • 项目类别:
LOCALIZED REVISION OF EPIGENETIC LANDSCAPES INDUCED BY DNA DOUBLE-STRAND BREAKS
DNA 双链断裂引起的表观遗传景观的局部修正
  • 批准号:
    8197622
  • 财政年份:
    2010
  • 资助金额:
    $ 39万
  • 项目类别:
TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS
针对非霍奇金淋巴瘤的表观基因组特征进行新疗法
  • 批准号:
    8699694
  • 财政年份:
    2010
  • 资助金额:
    $ 39万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了